Analyzing factors affecting return to work after shoulder replacement surgery
What Are the Determinants for Return to Work After Shoulder Arthroplasty
This study looks at how many people go back to work after shoulder replacement surgery and what factors might help or hinder their return.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | 18 Years to 63 Years |
| Sex | All |
| Sponsor | Universitaire Ziekenhuizen KU Leuven Academic / other |
| Locations | 1 site (Leuven, Vlaams-Brabant) |
| Trial ID | NCT06281574 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients who have undergone shoulder arthroplasty at the University Hospital Leuven. It aims to analyze the percentage of patients who return to work (RTW) after surgery and identify various factors that may influence this outcome. The study includes patients aged 18 to 63 who received specific types of shoulder implants between January 2010 and January 2022. By utilizing questionnaires, the research seeks to provide insights that can help surgeons offer tailored advice to their patients regarding their ability to return to work post-surgery.
Who should consider this trial
Good fit: Ideal candidates for this study are patients aged 18 to 63 who have undergone shoulder arthroplasty at the University Hospital Leuven.
Not a fit: Patients outside the age range of 18 to 63 or those with limited knowledge of Dutch may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could help improve patient outcomes by providing tailored guidance on return to work after shoulder replacement surgery.
How similar studies have performed: Other studies have shown success in analyzing return to work outcomes after orthopedic surgeries, making this approach relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Current evidence suggests that no significant changes in functionality can be expected 2 years after surgery. Therefore, we will include patients who were operated between January 2010 and January 2022 at the University Hospital Leuven * Patients ≥ 18 years old and ≤ 63 years old at time of surgery * Implantation of an anatomic total shoulder arthroplasty, humeral head hemi arthroplasty or reversed shoulder arthroplasty Exclusion Criteria: * Age \< 18 and \> 63 years at time of surgery * Limited knowledge of Dutch
Where this trial is running
Leuven, Vlaams-Brabant
- UZ Leuven — Leuven, Vlaams-Brabant, Belgium (Recruiting)
Study contacts
- Principal investigator: Filip Verhaegen — Universitaire Ziekenhuizen KU Leuven
- Study coordinator: Filip Verhaegen, Prof. Dr.
- Email: filip.verhaegen@uzleuven.be
- Phone: +32 16 33 88 27
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.